Main methods of biophysical enhancement in treating bone nonunions
It is estimated that between 5% and 10% of bone fractures do not heal properly [1]. The categories of bone fracture are the following: Closed or open fractures; complete fractures; displaced fractures; partial fractures; stress fractures. Some extra terms must also be added to describe partial, complete, open, and closed fractures. These terms include avulsion; comminuted; compression; impacted; oblique; spiral; transverse. Most often, bone fractures happen because the bone runs into a stronger force. Repetitive forces, such as running, can also fracture a bone (stress fractures). Another reason for fractures is osteoporosis, which weakens bones as you age.
Internal fixation for nonunions should provide sufficient stability for fracture healing without excessive rigidity. The choice of internal fixation depends on the type of nonunion, the condition of the soft tissues and bone, the size and position of the bone fragments, and the size of the bony defect [2]. Several biological enhancement methods have been published so far for managing nonunions (Table 1) [3,4,5].
Bone autograft |
Bone allograft (demineralized, cancellous, cortical) |
Demineralized bone matrix |
Reamer-irrigator-aspirator system |
Bone substitutes formed by collagen scaffolds, hydroxyapatite, and tricalcium phosphate |
Pulsed electromagnetic fields |
Low-intensity pulsed ultrasound |
Extracorporeal shock waves |
Percutaneous injection of autogenous bone marrow |
Platelet-rich plasma |
Bone morphogenetic proteins |
Stem cells: bone marrow aspirate |
Biphasic calcium phosphate bioceramic granules combined during surgery with autologous mesenchymal stem cells expanded from bone marrow |
There are, however, no current pharmacological treatments to enable effective bone consolidation. A better understanding of the molecular mechanisms underlying bone healing is therefore essential for developing new treatments to accelerate the process [1].
A biological or mechanical deficiency, a lack of information regarding the host’s comorbidities, and a lack of vascularization can all lead to nonunion. The presence of osteoinductive mediators, osteogenic cells, and an osteoconductive matrix (scaffolding) is paramount for proper unions. An optimal mechanical environment, appropriate vascularization, and treatment of any pre-existing comorbidity are also required for proper unions [4].
Factors that delay bone healing can be divided into local and systemic. The most important local factors are the following: inadequate bone reduction, unstable bone fixation, bone infection, and radiation. The most important systemic factors are the following: patient age (bone healing is faster in children than in adults), nutrition status (sufficient amount of nutrients and vitamins A, B, C, and D are essential for the healing of broken bones). Smoking has a negative effect on bone healing. Steroids also can slow down the healing process. Systemic diseases such as hyperthyroidism and renal insufficiency delay fracture healing. Genetic diseases such as Marfan syndrome, Ehler–Danlos syndrome, osteogenesis imperfecta are among the factors affecting bone healing.
Smoking causes delayed union and/or nonunion of bone fractures. Unfortunately, orthopedic surgeons rarely delay surgery in patients who smoke nor do they suggest methods for patients to quit smoking. It is important to recommend smoking cessation methods such as transdermal patches, chewing gum, lozenges, inhalers, sprays, bupropion, and varenicline during the perioperative period. Smoking cessation in the perioperative period appears to be effective in reducing delayed union and nonunion rates of bone fractures, even if performed up to 4 weeks prior to the surgery [73].
Hao et al. published a study in which they exposed three murine strains (C57BL/6J, 129 × 1/SvJ, and BALB/cJ) to cigarette smoke for 3 months before performing a midshaft transverse femoral osteotomy. Using radiography, microcomputed tomography, and biomechanical tests, the authors evaluated fracture healing 4 weeks after the osteotomy. The radiographic study showed a significant decrease in the fracture healing capacity of 129 × 1/SvJ smoke-exposed mice. The microcomputed tomography results showed a delay in the remodeling of the fracture calluses in all three strains after exposure to cigarette smoke. The biomechanical tests showed a more significant deterioration of functional properties in the 129 × 1/SvJ mice than in the C57BL/6J and BALB/cJ mice after exposure to cigarette smoke. In other words, the 129 × 1/SvJ strain was the most suitable for simulating the smoke-induced deterioration of fracture healing. In the 129 × 1/SvJ mice, the authors investigated the molecular and cellular disorders of fracture healing caused by cigarette smoke using histology, flow cytometry, and multiplex cytokine/chemokine analysis. The histological analysis showed abnormal chondrogenesis due to cigarette smoke exposure. In addition, significant populations of repair cells, including skeletal stem cells and their subsequent progenitors, showed a decrease in post-injury expansion as a result of cigarette smoke exposure. Furthermore, the authors observed a significant increase in pro-inflammatory mediators and immune cell recruitment in fracture hematomas in the mice exposed to smoke. These results show the important cellular and molecular disorders that occur during fracture healing due to smoking, such as abnormal chondrogenesis, aberrant activity of skeletal stem and progenitor cells, and an intense initial inflammatory response [74]. Table 3 shows the main factors that induce and delay bone healing according to recent publications on the molecular mechanisms of bone healing.
Table 3. Factors that induce and delay bone healing according to recent publications on the molecular mechanisms of bone healing.
Factors That Induce Bone Healing |
Type H vessels |
Endogenous-exogenous combined bionic periosteum |
Bone morphogenetic protein receptor type 2 |
Patch of synthetic biomaterial containing boronate molecules |
Paracrine cytokines released by macrophages |
Morin (a pale yellow crystalline flavonoid pigment [C15H10O7] found in old fustic and osage orange trees) |
The combined use of bone morphogenetic protein-9 and leptin |
Interleukin-1β |
Factors That Delay Bone Healing |
Inhibition of the estrogen receptor alpha signaling |
Tobacco smoking |
Deficiency of bone morphogenetic protein-6 (35 kDa)] |
This entry is adapted from the peer-reviewed paper 10.3390/ijms22020767